ZA855365B - Pharmaceutical formulations for ceftazidime - Google Patents
Pharmaceutical formulations for ceftazidimeInfo
- Publication number
- ZA855365B ZA855365B ZA855365A ZA855365A ZA855365B ZA 855365 B ZA855365 B ZA 855365B ZA 855365 A ZA855365 A ZA 855365A ZA 855365 A ZA855365 A ZA 855365A ZA 855365 B ZA855365 B ZA 855365B
- Authority
- ZA
- South Africa
- Prior art keywords
- ceftazidime
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
Links
- 229960000484 ceftazidime Drugs 0.000 title 1
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63373984A | 1984-07-23 | 1984-07-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA855365B true ZA855365B (en) | 1987-02-25 |
Family
ID=24540922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA855365A ZA855365B (en) | 1984-07-23 | 1985-07-16 | Pharmaceutical formulations for ceftazidime |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0169700B1 (de) |
| JP (1) | JPS6137728A (de) |
| CA (1) | CA1249969A (de) |
| DE (1) | DE3577656D1 (de) |
| IL (1) | IL75800A (de) |
| NZ (1) | NZ212763A (de) |
| ZA (1) | ZA855365B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3801179A1 (de) * | 1988-01-18 | 1989-07-27 | Hoechst Ag | Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten |
| DE3801178A1 (de) * | 1988-01-18 | 1989-07-27 | Hoechst Ag | Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung |
| RU2284832C2 (ru) * | 2004-08-30 | 2006-10-10 | Николай Александрович Киселев | Антимикробная композиция для перорального введения |
| CN108272753A (zh) * | 2018-02-07 | 2018-07-13 | 宁夏天心医药有限责任公司 | 一种头孢他啶粉针制剂及其制法 |
| CN113101274B (zh) * | 2021-03-31 | 2022-09-06 | 海南海灵化学制药有限公司 | 一种注射用头孢他啶粉针剂及其制备工艺 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5519237A (en) * | 1978-07-27 | 1980-02-09 | Toa Iyakuhin Kogyo Kk | Crystalline lactose with high beta-lactose content and diluent comprising it |
| US4329453A (en) * | 1979-10-02 | 1982-05-11 | Glaxo Group Limited | Cephalosporin antibiotic |
-
1985
- 1985-07-15 DE DE8585305051T patent/DE3577656D1/de not_active Expired - Lifetime
- 1985-07-15 IL IL75800A patent/IL75800A/xx not_active IP Right Cessation
- 1985-07-15 EP EP85305051A patent/EP0169700B1/de not_active Expired - Lifetime
- 1985-07-16 CA CA000486888A patent/CA1249969A/en not_active Expired
- 1985-07-16 ZA ZA855365A patent/ZA855365B/xx unknown
- 1985-07-17 NZ NZ212763A patent/NZ212763A/en unknown
- 1985-07-22 JP JP16279785A patent/JPS6137728A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE3577656D1 (de) | 1990-06-21 |
| IL75800A0 (en) | 1985-11-29 |
| EP0169700A3 (en) | 1987-05-13 |
| EP0169700A2 (de) | 1986-01-29 |
| JPS6137728A (ja) | 1986-02-22 |
| CA1249969A (en) | 1989-02-14 |
| EP0169700B1 (de) | 1990-05-16 |
| IL75800A (en) | 1988-11-30 |
| NZ212763A (en) | 1987-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2153678B (en) | Pharmaceutical composition | |
| DE3378523D1 (en) | Pharmaceutical formulations | |
| EP0163178A3 (en) | Pharmaceutical composition | |
| ZA824513B (en) | Pharmaceutical formulations | |
| GB2153677B (en) | Pharmaceutical composition | |
| GB8623389D0 (en) | Pharmaceutical formulations | |
| ZA855365B (en) | Pharmaceutical formulations for ceftazidime | |
| DE3466477D1 (en) | Pharmaceutical formulations | |
| ZA859077B (en) | Pharmaceutical compounds | |
| GB2153676B (en) | Pharmaceutical composition | |
| GB8419107D0 (en) | Pharmaceutical formulations | |
| GB8421741D0 (en) | Pharmaceutical formulations | |
| GB8421737D0 (en) | Pharmaceutical formulations | |
| ZA833692B (en) | Pharmaceutical formulations | |
| GB8603031D0 (en) | Pharmaceutical formulations | |
| IL91357A0 (en) | Pharmaceutical formulations containing certain benzimi-azolylmethyl benzenamides | |
| GB8316496D0 (en) | Pharmaceutical formulations | |
| GB8316498D0 (en) | Pharmaceutical formulations | |
| GB8300648D0 (en) | Pharmaceutical formulations | |
| GB8313036D0 (en) | Pharmaceutical formulations | |
| GB8316495D0 (en) | Pharmaceutical formulations | |
| GB8316497D0 (en) | Pharmaceutical formulations | |
| GB8332451D0 (en) | Pharmaceutical formulations | |
| GB8319759D0 (en) | Pharmaceutical formulations | |
| GB8319760D0 (en) | Pharmaceutical formulations |